Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Current and Projected Market Size of the Blood Plasma Derivatives Market Through 2034?

The market size for blood plasma derivatives has witnessed robust growth in the previous years. It is projected to increase from $51.81 billion in 2024 to $55.76 billion in 2025, enjoying a compound annual growth rate (CAGR) of 7.6%. The expansion during the historic period is linked to the rising incidence of hemophilia and bleeding issues, the increasing elderly population, heightened awareness and diagnoses, the escalation in surgical procedures, and worldwide blood transfusion services.

In the coming years, the market size for blood plasma derivatives is forecasted to undergo substantial growth, with an expectation to reach$79.09 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. Factors contributing to this growth during the projection period include the rise of therapies for rare diseases, an increase in chronic illnesses, a surge in healthcare spending, patient-focused treatment strategies, and an expansion in healthcare infrastructure. Major trends anticipated within this forecast period comprise advances in fractionation technologies, patient-focused actions, collaborations and partnerships, growing uses in neurology, and technological breakthroughs in plasma fractionation.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12107&type=smp

What External and Internal Drivers Are Contributing to the Growth of theBlood Plasma Derivatives Market?

The rise in immunodeficiency disorders is projected to fuel the expansion of the blood plasma derivatives market. These disorders, whether total or partial, compromise the immune system. Blood plasma derivatives are used to treat a range of medical problems, including immune deficiency disorders. Plasma, a mixture of proteins and salts, contains more than 100 different proteins, with immunoglobulins being particularly used to treat primary immunodeficiencies. Immune deficiency can be caused by poor or insufficient nutrition, resulting in macro- and micronutrient deficiencies. For example, in March 2022, the Allergy, Asthma & Clinical Immunology reported that the most prevalent condition was Common Variable Immunodeficiency (CVID), with a prevalence of 16.6% in the US, 12.9% internationally, and 13.9% globally. Consequently, the rising frequency of immune deficiency disorders is powering the expansion of the blood plasma derivatives market.

What Segment Types Define the Blood Plasma Derivatives Market Structure?

The blood plasma derivativesmarket covered in this report is segmented –

1) By Type: Albumin; Factor VIII; Factor IX; Immunoglobulin; Hyperimmune Globulin; Other Types

2) By Application: Hemophilia; Hypogammaglobulinemia; Immunodeficiency Diseases; Von Willebrand’s Disease; Other Applications

3) By End-User: Hospitals; Clinics; Other End-Users

Subsegments:

1) By Albumin: Human Serum Albumin; Recombinant Albumin

2) By Factor VIII: Plasma-Derived Factor VIII; Recombinant Factor VIII

3) By Factor IX: Plasma-Derived Factor IX; Recombinant Factor IX

4) By Immunoglobulin: Intravenous Immunoglobulin (IVIG); Subcutaneous Immunoglobulin (SCIG)

5) By Hyperimmune Globulin: Specific Pathogen-Reduced Hyperimmune Globulin; Standard Hyperimmune Globulin

6) By Other Types: Fibrinogen; Clotting Factor Concentrates; Plasma-Derived Proteins

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12107&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Blood Plasma Derivatives Market?

North America was the largest region in the blood plasma derivatives market in 2024. The regions covered in the blood plasma derivatives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Long-Term Trends Are Transforming the Competitive Landscape of the Blood Plasma Derivatives Market?

To gain a competitive edge in the blood plasma derivatives market, key companies are strategically partnering. Through these partnerships, a reliable and steady source of essential plasma-derived medicines will be provided for patients in need, satisfying the growing demand for immunoglobulins not only in France but globally. For example, in January 2022, Italy-based biopharmaceutical firm Kedrion S.p.A., which specializes in plasma-derived therapies development, production and distribution, collaborated with LPB, a UK-based pharmaceutical company that specializes in biological medicinal products. Kedrion will manufacture immunoglobulins in Hungary using LFB plasma sourced from France by the Etablissement Français du Sang (EFS). This supply of immunoglobulins will be increased by these imports from LFB in France, and will be provided to hospitals nationwide under the guidance of French health officials.

View the full report here:

https://www.thebusinessresearchcompany.com/report/blood-plasma-derivatives-global-market-report

What Is the Definition of the Blood Plasma Derivatives Market?

Blood plasma derivatives are medicinal products crafted from refined proteins found in blood plasma, encompassing clotting factors, albumins, and other proteins employed to treat diverse medical ailments. These derivatives hold significant significance as they aid in replenishing absent or inadequate proteins within the body.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12107

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model